Chief Business Officer · ARS Pharmaceuticals, Inc. · Common Stock
Side
M
Value
$25K
Shares
30.0K
Price
$0.84
Executed
Nov 12, 2025
Disclosed
Nov 14, 2025
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Nov 12 executedNov 14, 2025 disclosed
SPRY · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+9 / 25
$25K reported value · 22.0% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Chakma Justin filed this Form 4 reporting a option exercise of SPRY on Nov 12, 2025. It became public on Nov 14, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Business Officer
Chakma Justincik:0001951238
Issuer
ARS Pharmaceuticals, Inc.cik:0001671858
Revision history · 0
No field has changed since this record was first ingested.
